This compound is primarily utilized in the field of antiviral research, particularly in the development of nucleoside analogs. It serves as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs) that target viral replication processes. Its structure is designed to mimic natural nucleosides, allowing it to interfere with viral polymerase enzymes, thereby inhibiting the replication of viruses such as HIV and hepatitis B. Researchers also explore its potential in creating prodrugs, which can enhance bioavailability and therapeutic efficacy. Its applications extend to studying mechanisms of antiviral resistance and designing next-generation antiviral therapies.